Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC’s ‘Final Trades’
I'm LongbridgeAI, I can summarize articles.On CNBC’s 'Final Trades,' analysts highlighted key stocks: Jason Snipe recommended Netflix, citing a rebound and Bill Ackman's significant position. Bryn Talkington selected the Horizon Kinetics Inflation Beneficiaries ETF. Stephanie Link favored Elanco Animal Health due to strong Q2 results and raised guidance. Joseph Terranova predicted Eli Lilly would hit new highs, supported by its better-than-expected earnings and raised FY26 sales forecast.
On CNBC’s “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, recommended Netflix, Inc. (NASDAQ:NFLX).
The streaming service’s shares were trading higher on Tuesday, extending a recent rebound as the stock works to reclaim key moving averages. Meanwhile, Bill Ackman‘s Pershing Square fund disclosed last week a 3.15 million-share Netflix position, representing 4.9% of its portfolio.
Don’t forget to check out our premarket coverage here
Bryn Talkington, managing partner of Requisite Capital Management, picked Horizon Kinetics Inflation Beneficiaries ETF (NYSE:INFL) as her final trade.
Stephanie Link, chief investment strategist, head of investment solutions and equity portfolio manager at Hightower Advisors, said Elanco Animal Health Incorporated (NYSE:ELAN) has very strong fundamentals.
Lending support to her choice, Elanco Animal Health, on Aug. 5, reported better-than-expected second-quarter financial results and raised its FY26 guidance above estimates. Also, the company issued third-quarter sales guidance above estimates.
The pet health company reported adjusted earnings of 34 cents, beating the consensus of 27 cents. Sales jumped 10% year-over-year on a reported basis (+8% on constant currency) to $1.368 billion, better than the consensus of $1.313 billion.
Joseph M. Terranova, senior managing director for Virtus Investment Partners, said Eli Lilly and Company (NYSE:LLY) is about to make a new all-time high.
Supporting his view, Eli Lilly reported better-than-expected second-quarter financial results on Aug. 5 and raised its FY26 sales guidance, with the midpoint above estimates.
Price Action
- Horizon Kinetics Inflation Beneficiaries ETF fell 0.3% on Tuesday.
- Elanco Animal Health shares gained 0.1% to settle at $23.64 during the session.
- Eli Lilly shares gained 3.6% to close at $1,225.73 on Tuesday.
- Netflix shares rose 2.3% to close at $77.77 on Tuesday.
Read Also: Ackman Looks for Netflix Redemption: Here’s How Much He Could Have Made Holding His 2022 Stake
Photo via Shutterstock
